LTA4H Antibodies

Santa Cruz Biotechnology delivers a wide array of LTA4H monoclonal antibodies for investigating leukotriene A4 hydrolase (LTA4H) in various biological processes. LTA4H monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LTA4H is a crucial enzyme involved in the metabolism of leukotrienes, which are lipid mediators that play significant roles in inflammation and immune responses. By converting leukotriene A4 into leukotriene B4, LTA4H is integral to the regulation of inflammatory processes and has been implicated in various diseases, including asthma and cardiovascular disorders. Understanding the function of LTA4H is essential for developing targeted therapies aimed at modulating inflammatory responses. Research utilizing LTA4H monoclonal antibodies can reveal important insights into inflammatory pathways and disease mechanisms. Investigating LTA4H expression and activity patterns helps identify potential therapeutic approaches for inflammatory conditions. LTA4H monoclonal antibodies enable detailed examination of leukotriene metabolism and its impact on immune system function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of inflammatory diseases and developing new therapeutic strategies.